Using Patient-Reported Outcome Measures for Quality Improvement in Clinical Genetics: an Exploratory Study
A Costal Tirado1,2, A M McDermott3, C Thomas1
1Centre for Medical Education, School of Medicine, Cardiff University, Cardiff, UK.
Journal of Genetic Counseling
|March 11, 2017
Summary
Patient-reported outcome measures (PROMs) can improve healthcare quality. This study explored using PROMs in clinical genetics, identifying benefits like better patient insight and service evaluation.
Area of Science:
- Healthcare Quality Improvement
- Patient-Centered Care
- Clinical Genetics Services
Background:
- International advocacy promotes patient-centered healthcare delivery.
- Patient-reported outcome measures (PROMs) are key to evaluating healthcare from a patient perspective.
- Understanding the implementation processes for PROMs in healthcare settings remains limited.
Purpose of the Study:
- To explore the utilization of two different PROMs in clinical genetics services to support quality improvement.
- To identify challenges and benefits associated with implementing PROMs in a clinical genetics setting.
- To assess the utility of a genetic counseling-specific PROM (GCOS-24) and a generic PROM (EQ-5D).
Main Methods:
- An exploratory study involving the use of two PROMs: Genetic Counseling Outcome Scale (GCOS-24) and Euroqol (EQ-5D).
- A service audit tool based on patient-reported experience measures was also employed.
- Interviews with clinical staff were conducted to identify challenges and benefits of PROM implementation.
Main Results:
- PROMs provide valuable insights into patient needs and can complement clinical judgment.
- PROMs help identify met needs, evidence service benefits, and highlight areas for attention.
- Challenges in PROM use include response rates, data collection, and analysis, but benefits include professional development.
Conclusions:
- PROMs, including GCOS-24 and EQ-5D, can effectively support service quality improvement in clinical genetics.
- Successful implementation requires addressing challenges related to data management and staff engagement.
- Utilizing PROMs enhances patient-centered care by providing a direct patient perspective on healthcare outcomes and experiences.
Related Concept Videos
Guidelines for Writing Outcome
4.2K
When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
4.2K
Pharmacogenomics: Identification of New Drug Targets
55
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
55
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
510
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
510
Principles of Pharmacogenetics: Types of Genetic Variants
65
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
65
Pharmacogenetics and Pharmacogenomics: Overview
98
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
98
Genetic Screens
5.8K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.8K


